+Search query
-Structure paper
| Title | Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design. |
|---|---|
| Journal, issue, pages | Science, Page eaec6396, Year 2026 |
| Publish date | May 7, 2026 |
Authors | Ashwin N Skelly / Harry B Gristick / Hui Li / Edem Gavor / Andrew J Connell / Edward F Kreider / Lorie Marchitto / Michael P Hogarty / Maddy L Newby / Joel D Allen / Weimin Liu / Anthony P West / Kasirajan Ayyanathan / Mary S Campion / Kaitlyn Winters / Colette G Gordon / Rebecca A Osbaldeston / Macy J Akeley / Emily Lewis / Yingying Li / Ajay Singh / Kendra Cruickshank / Younghoon Park / Chengyan Zhao / Xuduo Li / Khaled Amereh / Elizabeth Van Itallie / John W Carey / Amie Albertus / Andrew T DeLaitsch / Jennifer R Keeffe / Melinda G Lituchy / Agnes A Walsh / Daniel J Morris / Rumi Habib / Frederic Bibollet-Ruche / Nitesh Mishra / Gabriel Avillion / Nicholas S Koranda / Samantha J Plante / Christian L Martella / Jinery Lora / Eric J D Wang / Mark G Lewis / Malcolm A Martin / Michel C Nussenzweig / Michael S Seaman / Darrell J Irvine / Kevin J Wiehe / Barton F Haynes / Kshitij Wagh / Bette Korber / Raiees Andrabi / Max Crispin / Drew Weissman / Pamela J Bjorkman / Beatrice H Hahn / George M Shaw / ![]() |
| PubMed Abstract | A major obstacle confronting HIV-1 vaccine and cure research is the lack of an outbred animal model for rapid and consistent induction of broadly neutralizing antibodies (bNAbs). We designed an ...A major obstacle confronting HIV-1 vaccine and cure research is the lack of an outbred animal model for rapid and consistent induction of broadly neutralizing antibodies (bNAbs). We designed an epitope-focused simian-human immunodeficiency virus (SHIV.5MUT) that elicited broad and potent V3-glycan-targeted antibodies within a year of infection in 14 of 22 macaques compared with 0 of 14 control animals. SHIV.5MUT elicited bNAbs by a two-step mechanism, inducing an initial wave of V1-directed antibodies that selected for Envs with shortened, hypoglycosylated V1 loops, which in turn primed V3-glycan bNAb precursors. Rhesus bNAbs were immunogenetically and structurally diverse, closely resembling human V3-glycan bNAbs. Env-bNAb coevolution revealed a diverse repertoire of bNAb precursors and the Env variants that matured them, yielding a molecular blueprint for vaccine design. |
External links | Science / PubMed:42096521 |
| Methods | EM (single particle) |
| Resolution | 3.0 - 5.0 Å |
| Structure data | EMDB-72969, PDB-9yho: EMDB-72970, PDB-9yhq: EMDB-72971, PDB-9yhr: EMDB-72973, PDB-9yht: EMDB-72985, PDB-9yib: EMDB-72986, PDB-9yid: EMDB-72987, PDB-9yie: EMDB-72988, PDB-9yif: EMDB-72989, PDB-9yig: EMDB-72990, PDB-9yih: EMDB-72991, PDB-9yii: EMDB-72992, PDB-9yij: EMDB-72993, PDB-9yik: EMDB-72994, PDB-9yil: |
| Chemicals | ![]() ChemComp-NAG: |
| Source |
|
Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / HIV-1 / Envelope protein / Vaccine / Immunogen / Antibody / bNAb / Viral Protein / VIRAL PROTEIN-IMMUNE SYSTEM complex |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links





























human immunodeficiency virus 1
Keywords